Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppression

Hormone and Metabolic Research

Volumn 43, Issue 1, 2011, Pages 22-25

  Sponziello, M L ^a   Bruno, R ^b   Durante, C ^a   D'Agostino, M ^c   Corradino, R ^c   Giannasio, P ^b   Ciociola, E ^a   Ferretti, E ^a   Maranghi, M ^a   Verrienti, A ^a   De Toma, G ^a   Filetti, S ^a   Russo, D ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Ospedale Civile di Tinchi Pisticci   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

IGF 1 receptor; insulin receptor; TSH

Indexed keywords

GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LEVOTHYROXINE; MESSENGER RNA; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THYROTROPIN; THYROTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROID NODULE; THYROIDECTOMY;

ADULT; AGED; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GOITER, NODULAR; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; THYROIDECTOMY; THYROTROPIN; THYROXINE;

EID: 78650945527     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1265226     Document Type: Article

References (20)

1. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002 87 4154-4159
2. Filetti S, Durante C, Torlontano M. Nonsurgical approaches to the management of thyroid nodules. Nat Clin Pract Endocrinol Metab 2006 2 384-394
3. Gharib H, Papini E, Paschke R. Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol 2008 159 493-505
4. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger P. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 2001 22 631-656
5. Bruno R, Ferretti E, Tosi E, Arturi F, Giannasio P, Mattei T, Scipioni A, Presta I, Morisi R, Gulino A, Filetti S, Russo D. Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: An in vivo effect of thyrotropin. J Clin Endocrinol Metab 2005 90 5692-5697
6. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989 63 908-911
7. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 402-408
8. Russo D, Bulotta S, Bruno R, Arturi F, Giannasio P, Derwahl M, Bidart JM, Schlumberger M, Filetti S. Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter. Eur J Endocrinol 2001 145 591-597
9. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009 19 1167-1214
10. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006 154 787-803
11. Derwahl M, Broecker M, Kraiem Z. Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 1999 84 829-834
12. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by Thyrotropin and other factors. Physiol Rev 1992 72 667-697
13. Frittitta L, Sciacca L, Catalfamo R, Ippolito A, Gangemi P, Pezzino V, Filetti S, Vigneri R. Functional insulin receptors are overexpressed in thyroid tumors: is this an early event in thyroid tumorigenesis? Cancer 1999 85 492-498
14. De Felice M, Postiglione MP, Di Lauro R. Thyrotropin receptor signaling in development and differentiation of the thyroid gland: insights from mouse models and human disease. Endocrinology 2004 145 4062-4067
15. Shinohara M, Chung YJ, Saji M, Ringel MD. AKT in Thyroid Tumorigenesis and Progression. Endocrinology 2007 148 942-947
16. De Vita G, Berlingieri MT, Visconti R, Castellone MD, Viglietto G, Baldassarre G, Zannini M, Bellacosa A, Tsichlis PN, Fusco A, Santoro M. Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiated and transforming effects. Cancer Res 2000 60 3916-3920
17. Saito J, Kohn AD, Roth RA, Hirai T, Kohn L, Ringel MD. Regulation of thyroid cell cycle progression and growth by insulin/IGF-1 via phosphotidylinositol 3 (OH)-kinase dependent AKT-mediated signaling. Thyroid 2001 11 339-351
18. Weidinger C, Karger S, Krause K, Schierle K, Steinert F, Gimm O, Dralle H, Fuhrer D. Distinct Regulation of Intrinsic Apoptosis in Benign and Malignant Thyroid Tumours. Horm Metab Res 2010 42 553-556
19. Mc Campbell AS, Broaddus RR, Loose DS, Davies PJA. Overexpression of the Insulin-Like Growth Factor I Receptor and activation of the AKT Pathway in Hyperplastic Endometrium. Clin Cancer Res 2006 12 6373-6378
20. Russo D, Arturi F, Pontecorvi A, Filetti S. Genetic analysis in fine needle aspiration biopsy of the thyroid: a new tool for the clinic. Trends Endocrinol Metab 1999 10 280-285